Works by de Jong, Igle J.

Results: 31

Does Computed Tomography or Positron Emission Tomography/Computed Tomography Contribute to Detection of Small Focal Cancers in the Prostate?
Published in:
Journal of Endourology, 2010, v. 24, n. 5, p. 693, doi. 10.1089/end.2009.0470
By:
- Li, Michael M.;
- Rybalov, Maxim;
- Haider, Masoom A.;
- de Jong, Igle J.
Publication type:
Article
Treatment and outcome in muscle invasive bladder cancer: a population-based survey.
Published in:
World Journal of Urology, 2010, v. 28, n. 4, p. 439, doi. 10.1007/s00345-010-0546-2
By:
- Leliveld, Anna M.;
- Doornweerd, Benjamin H. J.;
- Bastiaannet, Esther;
- Schaapveld, Michael;
- de Jong, Igle J.
Publication type:
Article
Compliance with biopsy recommendations of a prostate cancer risk calculator.
Published in:
BJU International, 2012, v. 109, n. 10, p. 1480, doi. 10.1111/j.1464-410X.2011.10611.x
By:
- van Vugt, Heidi A.;
- Roobol, Monique J.;
- Busstra, Martijn;
- Kil, Paul;
- Oomens, Eric H.;
- de Jong, Igle J.;
- Bangma, Chris H.;
- Steyerberg, Ewout W.;
- Korfage, Ida
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- Waarde, Aren van;
- O Dierckx, Rudi A. J.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, W.;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 29, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.253641
By:
- Antunes, Inês F.;
- Dost, Rutger J.;
- Hoving, Hilde D.;
- van Waarde, Aren;
- Dierckx, Rudi A. J. O.;
- Samplonius, Douwe F.;
- Helfrich, Wijnand;
- Elsinga, Philip H.;
- de Vries, Erik F. J.;
- de Jong, Igle J.
Publication type:
Article
18F-DCFPyL PET/CT in the Detection of Prostate Cancer at 60 and 120 Minutes: Detection Rate, Image Quality, Activity Kinetics, and Biodistribution.
Published in:
Journal of Nuclear Medicine, 2017, v. 58, n. 11, p. 1797, doi. 10.2967/jnumed.117.192658
By:
- Wondergem, Maurits;
- van der Zant, Friso M.;
- Knol, Remco J. J.;
- Lazarenko, Sergiy V.;
- Pruim, Jan;
- de Jong, Igle J.
Publication type:
Article
89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma.
Published in:
Journal of Nuclear Medicine, 2017, v. 58, n. 6, p. 905, doi. 10.2967/jnumed.116.183475
By:
- van Es, Suzanne C.;
- Brouwers, Adrienne H.;
- Mahesh, Shekar V. K.;
- Leliveld-Kors, Annemarie M.;
- de Jong, Igle J.;
- Lub-de Hooge, Marjolijn N.;
- de Vries, Elizabeth G. E.;
- Gietema, Jourik A.;
- Oosting, Sjoukje F.
Publication type:
Article
Molecular Imaging of Prostate Cancer: Tapping into the Opportunities.
Published in:
Journal of Nuclear Medicine, 2015, v. 56, n. 2, p. 169, doi. 10.2967/jnumed.114.150219
By:
- Oyen, Wim J. G.;
- De Jong, Igle J.
Publication type:
Article
89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.
Published in:
Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 63, doi. 10.2967/jnumed.114.144840
By:
- Oosting, Sjoukje F.;
- Brouwers, Adrienne H.;
- van Es, Suzanne C.;
- Nagengast, Wouter B.;
- Munnink, Thijs H. Oude;
- Lub-de Hooge, Marjolijn N.;
- Hollema, Harry;
- de Jong, Johan R.;
- de Jong, Igle J.;
- de Haas, Sanne;
- Scherer, Stefan J.;
- Sluiter, Wim J.;
- Dierckx, Rudi A.;
- Bongaerts, Alfons H. H.;
- Gietema, Jourik A.;
- de Vries, Elisabeth G. E.
Publication type:
Article
Tc-HDP bone scintigraphy and F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer.
Published in:
World Journal of Urology, 2018, v. 36, n. 1, p. 27, doi. 10.1007/s00345-017-2096-3
By:
- Wondergem, Maurits;
- van der Zant, Friso M.;
- Knol, Remco J. J.;
- Burgers, Anne Marij G.;
- Bos, Siebe D.;
- de Jong, Igle J.;
- Pruim, Jan
Publication type:
Article
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.
Published in:
Oncology, 2016, v. 91, n. 5, p. 267, doi. 10.1159/000448219
By:
- Badrising, Sushil K.;
- van der Noort, Vincent;
- Hamberg, Paul;
- Coenen, Jules L.L.M.;
- aarts, Maureen J.;
- van Oort, Inge M.;
- van den Eertwegh, alfons J.M.;
- Los, Maartje;
- van den Berg, H. Pieter;
- Gelderblom, Hans;
- Vrijaldenhoven, Suzan;
- Kerver, Emile D.;
- van Voorthuizen, Theo;
- de Jong, Igle J.;
- Haanen, John B.;
- Bergman, andries M.
Publication type:
Article
Platinum exposure and cause-specific mortality among patients with testicular cancer.
Published in:
2019
By:
- Groot, Harmke J;
- van Leeuwen, Flora E;
- Lubberts, Sjoukje;
- Horenblas, Simon;
- de Wit, Ronald;
- Witjes, J Alfred;
- Groenewegen, Gerard;
- Poortmans, Philip M;
- Hulshof, Maarten C C M;
- Meijer, Otto W M;
- de Jong, Igle J;
- van den Berg, Hetty A;
- Smilde, Tineke J;
- Vanneste, Ben G L;
- Aarts, Maureen J B;
- Jóźwiak, Katarzyna;
- van den Belt-Dusebout, Alexandra W;
- Gietema, Jourik A;
- Schaapveld, Michael
Publication type:
journal article
Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.
Published in:
Cancer (0008543X), 2014, v. 120, n. 7, p. 968, doi. 10.1002/cncr.28518
By:
- Badrising, Sushil;
- van der Noort, Vincent;
- van Oort, Inge M.;
- van den Berg, H. Pieter;
- Los, Maartje;
- Hamberg, Paul;
- Coenen, Jules L.;
- van den Eertwegh, Alfons J. M.;
- de Jong, Igle J.;
- Kerver, Emile D.;
- van Tinteren, Harm;
- Bergman, Andries M.
Publication type:
Article
EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study.
Published in:
International Journal of Molecular Sciences, 2017, v. 18, n. 8, p. 1802, doi. 10.3390/ijms18081802
By:
- van der Fels, Christa A. M.;
- Rosati, Stefano;
- de Jong, Igle J.
Publication type:
Article
EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study.
Published in:
International Journal of Molecular Sciences, 2016, v. 17, n. 10, p. 1650, doi. 10.3390/ijms17101650
By:
- Campos, Anna K.;
- Hoving, Hilde D.;
- Rosati, Stefano;
- van Leenders, Geert J. L. H.;
- de Jong, Igle J.
Publication type:
Article
PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy.
Published in:
International Journal of Molecular Sciences, 2014, v. 15, n. 4, p. 6046, doi. 10.3390/ijms15046046
By:
- Rybalov, Maxim;
- Ananias, Hildo J. K.;
- Hoving, Hilde D.;
- van der Poel, Henk G.;
- Rosati, Stefano;
- de Jong, Igle J.
Publication type:
Article
Prognostic Parameters for Response to Enzalutamide After Docetaxel and Abiraterone Treatment in Metastatic Castration-Resistant Prostate Cancer Patients; a Possible Time Relation.
Published in:
Prostate, 2016, v. 76, n. 1, p. 32, doi. 10.1002/pros.23094
By:
- Badrising, Sushil K.;
- van der Noort, Vincent;
- van den Eertwegh, Alfons J.M.;
- Hamberg, Paul;
- van Oort, Inge M.;
- van den Berg, Hendrik P.;
- Los, Maartje;
- Aarts, Maureen J.B.;
- Coenen, Jules L.L.M.;
- Gelderblom, Hans;
- de Jong, Igle J.;
- Kerver, Emile D.;
- Vrijaldenhoven, Suzan;
- van Voorthuizen, Theo;
- Warmerdam, Fabienne;
- Haanen, John B.;
- Bergman, Andries M.
Publication type:
Article
Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.
Published in:
Prostate, 2009, v. 69, n. 10, p. 1101, doi. 10.1002/pros.20957
By:
- Ananias, Hildo J.K.;
- van den Heuvel, Marius C.;
- Helfrich, Wijnand;
- de Jong, Igle J.
Publication type:
Article
Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal Fibrosis.
Published in:
Pharmaceutics, 2020, v. 12, n. 5, p. 459, doi. 10.3390/pharmaceutics12050459
By:
- Bigaeva, Emilia;
- Puerta Cavanzo, Nataly;
- Stribos, Elisabeth G. D.;
- de Jong, Amos J.;
- Biel, Carin;
- Mutsaers, Henricus A. M.;
- Jensen, Michael S.;
- Nørregaard, Rikke;
- Leliveld, Anna M.;
- de Jong, Igle J.;
- Hillebrands, Jan-Luuk;
- van Goor, Harry;
- Boersema, Miriam;
- Bank, Ruud A.;
- Olinga, Peter
Publication type:
Article
In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2005, v. 32, n. 6, p. 668, doi. 10.1007/s00259-004-1741-4
By:
- Breeuwsma, Anthonius J.;
- Pruim, Jan;
- Jongen, Maud M.;
- Suurmeijer, Albert J.;
- Vaalburg, Wim;
- Nijman, Rien J.;
- de Jong, Igle J.
Publication type:
Article
Visualisation of bladder cancer using [sup 11] C-choline PET: first clinical experience.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2002, v. 29, n. 10, p. 1283, doi. 10.1007/s00259-002-0881-7
By:
- de Jong, Igle J.;
- Pruim, Jan;
- Elsinga, Philip H.;
- Jongen, Maud J.;
- Mensink, Han A.;
- Vaalburg, Willem
Publication type:
Article
Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment.
Published in:
Cancers, 2021, v. 13, n. 22, p. 5675, doi. 10.3390/cancers13225675
By:
- Stelwagen, Johannes;
- Meuleman, Andrea T.;
- Lubberts, Sjoukje;
- Steursma, Gerrie;
- Kruyt, Lara M.;
- Donkerbroek, Jan W.;
- Meijer, Coby;
- Walenkamp, Annemiek M. E.;
- Lefrandt, Joop D.;
- Rakers, Sandra E.;
- Huitema, Rients B.;
- de Jong, Marianne A. A.;
- Wiegman, Erwin M.;
- van den Bergh, Alfons C. M.;
- de Jong, Igle J.;
- van Rentergem, Joost A. Agelink;
- Schagen, Sanne B.;
- Nuver, Janine;
- Gietema, Jourik A.
Publication type:
Article
Response to: Fu-Xiang Lin, Yi Yu, Zhan-Ping Xu Letter to Editor: Unveiling the Crystal Clear: Cone Beam Computed Tomography's Role in Enhancing PCNL Outcomes and the Path Forward.
Published in:
Journal of Endourology, 2024, v. 38, n. 11, p. e1241, doi. 10.1089/end.2024.0452
By:
- Altobelli, Emanuela;
- Kingma, Riemer;
- Mors, Rianne;
- Bus, Mieke T.J.;
- de Jong, Igle J.;
- Roemeling, Stijn
Publication type:
Article
Preoperative Staging of Pelvic Lymph Nodes in Prostate Cancer by 11C-Choline PET.
Published in:
Journal of Nuclear Medicine, 2003, v. 44, n. 3, p. 331
By:
- De Jong, Igle J.;
- Pruim, Jan;
- Elsinga, Philip H.;
- Vaalburg, Willem;
- Mensink, Han J.
Publication type:
Article

Works by de Jong, Igle J.

Does Computed Tomography or Positron Emission Tomography/Computed Tomography Contribute to Detection of Small Focal Cancers in the Prostate?

Treatment and outcome in muscle invasive bladder cancer: a population-based survey.

Compliance with biopsy recommendations of a prostate cancer risk calculator.

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.

<sup>18</sup>F-DCFPyL PET/CT in the Detection of Prostate Cancer at 60 and 120 Minutes: Detection Rate, Image Quality, Activity Kinetics, and Biodistribution.

<sup>89</sup>Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma.

Molecular Imaging of Prostate Cancer: Tapping into the Opportunities.

<sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.

Tc-HDP bone scintigraphy and F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer.

Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.

Platinum exposure and cause-specific mortality among patients with testicular cancer.

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.

EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study.

EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study.

PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy.

Prognostic Parameters for Response to Enzalutamide After Docetaxel and Abiraterone Treatment in Metastatic Castration-Resistant Prostate Cancer Patients; a Possible Time Relation.

Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.

Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal Fibrosis.

In vivo uptake of [<sup>11</sup>C]choline does not correlate with cell proliferation in human prostate cancer.

Visualisation of bladder cancer using [sup 11] C-choline PET: first clinical experience.

Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment.

Response to: Fu-Xiang Lin, Yi Yu, Zhan-Ping Xu Letter to Editor: Unveiling the Crystal Clear: Cone Beam Computed Tomography's Role in Enhancing PCNL Outcomes and the Path Forward.

Preoperative Staging of Pelvic Lymph Nodes in Prostate Cancer by <sup>11</sup>C-Choline PET.